Seaside Therapeutics Initiates Phase 2b Study Of STX209 In Autism Spectrum Disorders
Friday, Aug. 5th 2011 6:40 AM
Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 2b study to evaluate the effects of STX209 (arbaclofen) on social impairment in children, adolescents and adults (ages 5 to 21) with autism spectrum disorders (ASD). The Company announced positive results from an open-label Phase 2a study of STX209 in September of 2010.
Related posts:
- Dietary Issues In Children With Autism Spectrum Disorders Children with autism spectrum disorders (ASD) can demonstrate feeding problems, food refusal, and limited food preferences from infancy, but energy intake and growth are not affected…...
- Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders...
- The Autistic Mind: New Studies Show Spectrum Of Gene Variants Different people with autism can have very different symptoms. Health care providers think of autism as a “spectrum” disorder (ASD), a group of disorders with similar features. One person may have mild symptoms, while another may have serious symptoms. But they both have an autism spectrum disorder....
- Pitt Study Examines Environmental Risk Factors For Childhood Autism The University of Pittsburgh Graduate School of Public Health (GSPH) has launched a multi-year study to help identify environmental and other factors that may put children at risk for developing conditions within the autism spectrum disorders (ASDs)....
- Johns Hopkins Researchers Create New Mouse Model Of Autism In an effort to unravel the tangled biology of autism, Johns Hopkins scientists have created a mouse model that mimics a human mutation of a gene known to be associated with autism spectrum disorders. Experiments with the engineered mouse reveal a molecular mechanism by which mutations of the gene named Shank3 affect the brain and […]...
- New Technology Reveals A Unique Vocal Signature In Autism A new automated vocal analysis technology could fundamentally change the study of language development as well as the screening for autism spectrum disorders and language delay, reports a study in the July 19 online Proceedings of the National Academy of Sciences…...
- Research Provides Important Insight Into ‘Systemizing’ Theory Of Autism A new study from Cambridge University has for the first time found that autism diagnoses are more common in an IT-rich region. The Medical Research Council (MRC) funded study, published in the Journal of Autism and Developmental Disorders, has important implications for service provision in different regions and for the ‘hyper-systemizing’ theory of autism....
- Autism Detected In Unique Vocal Signature Of Baby Talk Using a new type of “vocal signature” technology that focuses on sound patterns rather than words in child vocalizations and baby talk, researchers in the US say they have proved in principle that it is possible to screen for autism spectrum disorders in young children; they also hope the new method will greatly enhance the […]...
- Researchers Develop Mouse Model To Help Find How A Gene Mutation Leads To Autism Researchers Develop Mouse Model To Help Find How A Gene Mutation Leads To Autism...
- Study Aims To Uncover Source Of Sensory Problems In Autism The way the brain reacts differently to the sense of touch in people with Autism will be examined as part of an innovative Cardiff University study designed to create better understanding of the condition in Autism....
- Teva Respiratory Announces Positive Results From Phase III Trial Of BDP HFA Nasal Aerosol In Seasonal Allergic Rhinitis Teva Respiratory announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to a placebo....
- Study Linking Autism To MMR Vaccine “An Elaborate Fraud” Study Linking Autism To MMR Vaccine "An Elaborate Fraud"...
- Genetic Causation Of ASD Appears To Be Highly Diverse; Thoughts On Why Fewer Girls Have Autism A clinically extensive and mathematically powerful study of 1000 families with one autistic child and one unaffected sibling has validated a controversial theory of autism’s complex genetic causation. The study for the first time estimates the minimum number of locations in the human genome — 250 to 300 — where gene copy number variation (CNV) […]...
- Weaker Brain "Sync" May Be Early Sign Of Autism In a novel imaging study of sleeping toddlers, scientists at the University of California, San Diego Autism Center of Excellence report that a diminished ability of a young brain’s hemispheres to “sync” with one another could be a powerful, new biological marker of autism, one that might enable an autism diagnosis at a very young […]...
Posted on Friday, Aug. 5th 2011 6:40 AM | by Share of Cost | in Share of Cost | No Comments »